Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Landers

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2017
Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse SurvivalDaniel J Boffa, Ryon P Graf, Michelle C Salazar, et al.
Cancer Research|August 21, 2020
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate CancerJoseph D Schonhoft, Jimmy L Zhao, Adam Jendrisak, et al.
Cancer Research|August 19, 2017
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Pediatric Transplantation|July 16, 2017
Effect of thyroid hormone on cardiac function following orthotopic heart transplantation in pigletsT K Susheel Kumar, Craig Mathis, Shyam Sathanandam, et al.
BJU International|August 20, 2016
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancerAndrew S McDaniel, Roberta Ferraldeschi, Rachel Krupa, et al.
Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.
The Journal of Urology|June 20, 2019
Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate CancerTerence W Friedlander, Christopher Welty, Archana Anantharaman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2017
Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse SurvivalDaniel J Boffa, Ryon P Graf, Michelle C Salazar, et al.
Cancer Research|August 21, 2020
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate CancerJoseph D Schonhoft, Jimmy L Zhao, Adam Jendrisak, et al.
Cancer Research|August 19, 2017
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Pediatric Transplantation|July 16, 2017
Effect of thyroid hormone on cardiac function following orthotopic heart transplantation in pigletsT K Susheel Kumar, Craig Mathis, Shyam Sathanandam, et al.
BJU International|August 20, 2016
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancerAndrew S McDaniel, Roberta Ferraldeschi, Rachel Krupa, et al.
Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.
The Journal of Urology|June 20, 2019
Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate CancerTerence W Friedlander, Christopher Welty, Archana Anantharaman, et al.
Pageof 2